255 related articles for article (PubMed ID: 3129659)
1. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.
de Préval C; Hadam MR; Mach B
N Engl J Med; 1988 May; 318(20):1295-300. PubMed ID: 3129659
[TBL] [Abstract][Full Text] [Related]
2. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
[TBL] [Abstract][Full Text] [Related]
3. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
5. Combined immunodeficiency with defective expression in MHC class II genes.
Griscelli C; Lisowska-Grospierre B; Mach B
Immunodefic Rev; 1989; 1(2):135-53. PubMed ID: 2517209
[TBL] [Abstract][Full Text] [Related]
6. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
7. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
10. Type III bare lymphocyte syndrome: lack of HLA class II gene expression and reduction in HLA class I gene expression.
Sabatier C; Gimenez C; Calin-Laurens V; Rabourdin-Combe C; Touraine JL
C R Acad Sci III; 1996 Sep; 319(9):789-98. PubMed ID: 8952882
[TBL] [Abstract][Full Text] [Related]
11. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
12. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
14. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
15. Modulation of MHC class II expression in human cells by dexamethasone.
Schwiebert LM; Schleimer RP; Radka SF; Ono SJ
Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315
[TBL] [Abstract][Full Text] [Related]
16. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon.
Wang D; Levasseur-Acker GM; Jankowski R; Kanny G; Moneret-Vautrin DA; Charron D; Lockhart A; Swierczewski E
Clin Exp Allergy; 1997 Mar; 27(3):306-14. PubMed ID: 9088657
[TBL] [Abstract][Full Text] [Related]
17. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
19. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
